Latest Bayer HealthCare LLC Stories

TARRYTOWN, N.Y., Sept. 23 /PRNewswire/ -- According to a new study, people with diabetes, especially those treated with insulin, may achieve optimal blood sugar control when they understand the impact of food on blood sugar and they utilize useful advanced blood glucose meter (BGM) features such as meal markers and audible reminders. These findings, presented at the 46th European Association for the Study of Diabetes (EASD) Annual Meeting in Stockholm, Sweden, are important because...

MORRISTOWN, N.J., July 12 /PRNewswire/ -- Timothy G. Hayes, currently Senior Vice President and Region Head for Bayer HealthCare's Consumer Care Division in North America, will also lead the business unit's Global Business Development function effective July 1. In addition to his role leading Bayer HealthCare's over-the-counter (OTC) drug business in the United States, Canada and Puerto Rico, Hayes will now also oversee new business development for Consumer Care's global brand portfolio and...

WAYNE, N.J., EMERYVILLE, Calif. and MELVILLE, N.Y., May 28 /PRNewswire-FirstCall/ -- Bayer HealthCare LLC., Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX), OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) and Roche today announced the initiation of a Phase 3 trial examining Nexavar(R) (sorafenib) tablets in combination with Tarceva(R) (erlotinib) tablets as a potential new treatment option for patients with advanced hepatocellular carcinoma (HCC), or primary liver cancer. The SEARCH (Sorafenib and...

Makers of Bayer Aspirin Announce Support of National Women's Heart Health Organization Through Educational Grant MORRISTOWN, N.J., Feb. 9 /PRNewswire/ -- Bayer HealthCare LLC, the makers of Bayer(R) Aspirin, announced today their support of WomenHeart, the nation's only education and advocacy organization solely dedicated to promoting women's heart health, with a $100,000 educational grant from the Bayer USA Foundation. An estimated 44 million American women live with or are at risk of...

NEW YORK, Feb. 3 /PRNewswire/ -- Though one in three women in this country has some form of heart disease, women are still not receiving the same in-hospital treatment that men do for heart attacks and as a result, may be more likely to die. (Please copy and paste the following link into your podcast feed aggregator: http://podcaster.medialink.com/?StrongAtHeart) This disparity in care is a big concern. For example, women are 14% less likely than men to be treated with aspirin following...

- Strong @Heart Campaign Encourages the 44 Million Women Living with or at Risk of Heart Disease to Become Advocates for Women's Heart Health - WASHINGTON, Feb. 2 /PRNewswire/ -- Heart disease is the #1 killer of women in the U.S.,(i) yet women are still not receiving the same in-hospital treatment that men do for heart attacks and as a result, they may be more likely to die.(ii) In an effort to address this problem, Bayer Healthcare LLC, the makers of Bayer Aspirin, and WomenHeart, the...

The European Medicines Agency (EMEA) has granted license approval to Bayer HealthCare LLC (Bayer) for its new sterile filling facility (SFF) on its Berkeley, Calif. campus. The approval closely follows authorization already given by the U.S. Food and Drug Administration in August 2008. Together, these licenses from the regulatory bodies ensure this state-of-the-art facility is ready to support the supply of Bayer's Kogenate(R) FS/ KOGENATE(R) Bayer (Antihemophilic Factor (Recombinant)) line...

BERKELEY, Calif., Oct. 10 /PRNewswire/ -- Bayer HealthCare LLC announced today that the U.S. Food and Drug Administration (FDA) has approved routine prophylaxis with Kogenate(R) FS Antihemophilic Factor (Recombinant) to reduce the frequency of bleeding episodes and the risk of joint damage in patients aged 0-16 years with severe hemophilia A with no pre-existing joint damage. This important approval provides these patients with the only factor VIII treatment that the FDA has determined safe...

MORRISTOWN, N.J., Sept. 22 /PRNewswire/ -- A new survey of men and women age 40 and older in the United States reveals a significant gap between people's desire to avoid taking risks with their health, and the percentage who knowingly skip critical health screenings. Overall, 60 percent indicated they weren't risk takers with their health. Yet, 25 percent of those who think they play it safe admitted to skipping routine mammograms or prostate cancer screenings, with 30 percent skipping...